Frost & Sullivan

AUGUST 6, 2023

San Antonio, TX — 7 th Aug, 2023 — Frost & Sullivan recently researched the Asia-Pacific biotechnology contract research organization industry and, based on its findings, recognizes Avance Clinical with the 2023 Customer Value Leadership Award.

Biotechnology

Frost & Sullivan

MARCH 8, 2021

Based on its recent analysis of the North American contract research organization (CRO) market in dermatology, Frost & Sullivan recognizes TergusPharma (Tergus) with the 2020 North America Customer Value Leadership Award.

Biotech

Frost & Sullivan

JULY 31, 2024

This shift is benefiting pharmaceutical companies and contract research organizations (CROs) by facilitating decentralized trials, simplifying patient recruitment and retention, and reducing the number of phase 3 clinical sites. Central contracts with retailers are providing convenient access to numerous trial locations.

Retail

Frost & Sullivan

JULY 31, 2024

This shift is benefiting pharmaceutical companies and contract research organizations (CROs) by facilitating decentralized trials, simplifying patient recruitment and retention, and reducing the number of phase 3 clinical sites. Central contracts with retailers are providing convenient access to numerous trial locations.

Retail

Frost & Sullivan

OCTOBER 26, 2023

The esteemed recipients of the Frost & Sullivan Best Practice Awards include the following: Accelovant – 2023 North American Fiber-optic Temperature Measurement Solutions New Product Innovation Award AT&T – 2023 United States Next Generation 9-1-1 Market Leadership Award Avance Clinical – 2023 Asia-Pacific Biotech Contract (..)

Biotech

Frost & Sullivan

AUGUST 29, 2024

This is fueling the growing demand for outsourcing, with contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs) driving industry growth. Conversely, small-to-mid, and emerging biopharma players, with 1 or 2 molecules in the pipeline, contribute over 16%.

Biopharma

Frost & Sullivan

AUGUST 21, 2024

Contract research organizations (CROs) and pharmaceutical companies are using AI to refine their go-to-market strategies, improve patient recruitment, and enhance retention for decentralized trials.

Contract research organization

Jake Jorgovan

FEBRUARY 1, 2024

CSSi LifeSciences CSSi LifeSciences is a global, innovative Contract Research Organization (CRO) and consulting group specializing in advancing therapeutics and medical devices through development and regulatory approval. The company provides customized solutions to mitigate risks, time, and expenses, supporting U.S.

Life science

Frost & Sullivan

JULY 19, 2021

Parexel was named “Best Contract Research Organization” in December 2020 by an independent panel for Informa Pharma Intelligence. For more information, visit parexel.com and follow us on LinkedIn , Twitter , and Instagram.

Biopharmaceuticals

Frost & Sullivan

FEBRUARY 15, 2024

Small- to mid-sized pharma/biotech players in APAC are rivaling Europe in clinical trials through multiple CRO partnerships in the region, tapping into a population-rich landscape.

Ecosystems

Frost & Sullivan

MARCH 22, 2024

Growing demand for outsourcing, with contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs) leading industry growth. Top 10 pharma companies contribute only 4-5% to R&D pipeline; top 25 contribute less than 10%.

Biopharma

Frost & Sullivan

APRIL 25, 2023

April 25, 2023 – Frost & Sullivan researched the contract research organizations industry and, based on its analysis results, recognizes Emmes with the 2023 Global Competitive Strategy Leadership Award. SAN ANTONIO, TX.

Biopharmaceuticals

Frost & Sullivan

APRIL 11, 2023

Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry. About Inotiv Inotiv, Inc.

Biotech

Frost & Sullivan

AUGUST 5, 2021

. “ArisGlobal is currently developing device-specific functionalities and product-compliant modules to extend its integrated solution across domains,” noted Ojaswi Rana, Best Practices Research Analyst for Frost & Sullivan.

Life science

Frost & Sullivan

JULY 9, 2024

This technology supports large clientele, small and medium-sized contract research organizations (CROs) and Biotechnology medical device and pharmaceutical companies within the broader life science sector.

Life science

Frost & Sullivan

JANUARY 30, 2023

SAN ANTONIO – January 30, 2022 – Frost & Sullivan recently analyzed the Asia-Pacific contract research organization industry and, based on its findings, recognizes Novotech with the 2022 Asia-Pacific Contract Research Organization Company of the Year Award.

Biotech

Frost & Sullivan

OCTOBER 24, 2024

The prestigious 2024 Frost & Sullivan Best Practices Awards were presented to the following companies for their outstanding contributions: Ansell – 2024 Global Hospital Supplies Company of the Year Award ARC Group Limited – 2024 Asian Mid-market Investment Advisory Services Company of the Year Award Avance Clinical – 2024 Global Biotech (..)

Biotech

Frost & Sullivan

OCTOBER 24, 2024

The prestigious 2024 Frost & Sullivan Best Practices Awards were presented to the following companies for their outstanding contributions: Ansell – 2024 Global Hospital Supplies Company of the Year Award ARC Group Limited – 2024 Asian Mid-market Investment Advisory Services Company of the Year Award Avance Clinical – 2024 Global Biotech (..)

Biotech

Frost & Sullivan

MARCH 28, 2025

Innovating for Growth: The Future of Biotech CROs The biotech Contract Research Organization (CRO) industry is undergoing a rapid transformation, driven by technological advancements, globalization, and evolving patient needs. What are the top three trends you see driving change? Yvonne Lungershausen: Thank you, Unmesh.

Biotech

Frost & Sullivan

MAY 13, 2025

About Avance Clinical Avance Clinical is a leading Contract Research Organization (CRO) offering biotech companies faster, more flexible, and higher-quality clinical trial services.

Biotech

Frost & Sullivan

FEBRUARY 12, 2025

13 th February 2025 Frost & Sullivan recently analyzed the biotechnology contract research organization (CRO) industry and, based on its findings, recognizes Southern Star Research with the 2024 Asia-Pacific Competitive Strategy Leadership Award. SAN ANTONIO, TX.

Biotech

Frost & Sullivan

OCTOBER 11, 2024

San Antonio, TX — 14 th October 2024 — Frost & Sullivan recently conducted an in-depth analysis of the biotech contract research organization (CRO) industry and based on its findings, has awarded Novotech the 2024 Global Company of the Year Award.

Biotech

Jake Jorgovan

FEBRUARY 2, 2025

CSSi LifeSciences CSSi LifeSciences is a global, innovative Contract Research Organization (CRO) and consulting group specializing in advancing therapeutics and medical devices through development and regulatory approval. The company provides customized solutions to mitigate risks, time, and expenses, supporting U.S.

Life science

Frost & Sullivan

MAY 9, 2025

The Expanding Role of Clinical Contract Peripheral Services As the pharmaceutical and biopharma industries recalibrate after the COVID-19 pandemic, clinical trial outsourcing has surged, creating significant opportunities for contract research organizations (CROs). The global CRO industry, valued at $66.39

Mergers and acquisition activities

Frost & Sullivan

JUNE 27, 2025

Learn more about Airsys: airsysnorthamerica.com Novotech 2025 Global Biotechnology Contract Research Organization Company of the Year Award Novotech has redefined the biotech CRO landscape with a client-centric approach tailored to the needs of small to mid-sized biotech and pharma innovators.

Biotech

Frost & Sullivan

MAY 12, 2025

John Moller : We aim to be the global CRO (Contract Research Organization) of choice for biotech and small to mid-size pharma. And third, the globalization of clinical development, as companies increasingly pursue multi-regional trials much earlier in the drug development lifecycle.

Biotech